Arbor Capital Management Inc. ADV Has $1.34 Million Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Arbor Capital Management Inc. ADV increased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 3.8% in the 4th quarter, Holdings Channel.com reports. The firm owned 2,484 shares of the healthcare conglomerate’s stock after acquiring an additional 91 shares during the quarter. Arbor Capital Management Inc. ADV’s holdings in UnitedHealth Group were worth $1,335,000 as of its most recent filing with the SEC.

Several other large investors have also made changes to their positions in UNH. IMG Wealth Management Inc. acquired a new position in UnitedHealth Group in the 4th quarter valued at approximately $177,000. GLOBALT Investments LLC GA raised its holdings in UnitedHealth Group by 45.6% in the 4th quarter. GLOBALT Investments LLC GA now owns 18,793 shares of the healthcare conglomerate’s stock valued at $9,507,000 after acquiring an additional 5,890 shares in the last quarter. Signature Wealth Management Group raised its holdings in UnitedHealth Group by 2.7% in the 4th quarter. Signature Wealth Management Group now owns 3,724 shares of the healthcare conglomerate’s stock valued at $1,884,000 after acquiring an additional 97 shares in the last quarter. SlateStone Wealth LLC raised its holdings in UnitedHealth Group by 0.8% in the 4th quarter. SlateStone Wealth LLC now owns 10,583 shares of the healthcare conglomerate’s stock valued at $5,354,000 after acquiring an additional 86 shares in the last quarter. Finally, Nicholas Company Inc. raised its holdings in UnitedHealth Group by 2.2% in the 4th quarter. Nicholas Company Inc. now owns 142,641 shares of the healthcare conglomerate’s stock valued at $72,156,000 after acquiring an additional 3,031 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Analyst Ratings Changes

Several brokerages recently commented on UNH. HSBC raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price target on the stock in a research note on Friday, January 10th. Deutsche Bank Aktiengesellschaft increased their target price on shares of UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a research report on Tuesday, December 3rd. Hsbc Global Res raised shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research note on Friday, January 10th. Stephens boosted their target price on UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a report on Thursday, December 5th. Finally, Barclays cut their price objective on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a research report on Friday, January 17th. Twenty equities research analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Buy” and an average price target of $629.32.

UnitedHealth Group Stock Performance

UNH stock opened at $488.52 on Monday. The business’s fifty day moving average is $511.36 and its 200-day moving average is $549.80. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The company has a market cap of $446.85 billion, a P/E ratio of 31.52, a price-to-earnings-growth ratio of 1.37 and a beta of 0.62. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $630.73.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping the consensus estimate of $6.74 by $0.07. The business had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm’s revenue was up 6.8% compared to the same quarter last year. During the same quarter last year, the business posted $5.83 EPS. Equities research analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 18th. Investors of record on Monday, March 10th will be paid a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a yield of 1.72%. The ex-dividend date is Monday, March 10th. UnitedHealth Group’s payout ratio is presently 54.19%.

Insider Buying and Selling

In other news, Director Timothy Patrick Flynn bought 1,000 shares of the stock in a transaction on Friday, January 17th. The stock was purchased at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the acquisition, the director now owns 4,500 shares in the company, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. 0.33% of the stock is currently owned by company insiders.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.